CRL-1072 enhances antimycobacterial activity of human macrophages through interleukin-8

Journal of Interferon and Cytokine Research

Volumn 19, Issue 1, 1999, Pages 67-76

  Jagannath, Chinnaswamy ^a,b   Pai, Suresh ^a   Actor, Jeffrey K ^a   Hunter Jr , Robert L ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CRL 1072; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; INTERLEUKIN 8; MESSENGER RNA; MYELOPEROXIDASE; NITRIC OXIDE; POLOXAMER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL;

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-8; MACROPHAGES; MICROBIAL SENSITIVITY TESTS; MONOCYTES; MYCOBACTERIUM AVIUM; NEUTROPHILS; PEROXIDASE; POLOXAMER; SURFACE-ACTIVE AGENTS; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 0032938646     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099314432     Document Type: Article

References (44)

1. HUNTER, R.L., JAGANNATH, C., TINKLEY, A., BEHLING, C.A., and NOLTE, F. (1995). Suppression of the growth of My- cobacterium aviuim by poloxamer 331. Antimicrob. Agents Chemother. 39, 435.
2. JAGANNATH, C., ALLAUDEEN, H.S., and HUNTER. R.L. (1995). Activity of poloxamer CRL-8131 against Mycobacterium tuberculosis in vitro and in vivo. Antimicrob. Agents Chemother. 39, 1349-1354.
3. JAGANNATH, C., EMANUELE, R.M., and HUNTER, R.L. (1999). Activity of poloxamer CRL-1072 against drug-sensitive and resistant strains of Mycobacterium tuberculosis in macrophages and mice. Int. J. Antimicrob. Agents (in press).
4. JAGANNATH, C., EMANUELE, R.M., and HUNTER, R.L. (1999). Activity of poloxamer CRL-1072 against Mycobacterium avium in macrophages and mice. Antimicrob. Agents Chemother. (in press).
5. HOWERTON, D.A., HUNTER, R.L., ZIEGLER, H.K., and CHECK, I.J. (1990). The induction of macrophage la expression in vivo by a synthetic copolymer, L81. J. Immunol. 144, 1558.
6. NEWMAN, J., ACTOR, J.K., BALASUBRAMANIAN, M., and JAGANNATH, C. (1998). Use of nonionic block copolymers in vaccines and therapeutics. Crit. Rev. Drug Carrier Systems 15, 1-59.
7. MUKAIDA, N., HARADA, A., YASUMOTO, K., and MATSUSHIMA, K. (1992). Properties of proinflammatory cell type specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factors (MACF). Microbiol. Immunol. 36, 773-779.
8. MURPHY, P.M. (1997). Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin. Hematol. 34, 311-318.
9. STANDIFORD, T.J., KUNKEL, S.L., and STRIETER, R.M. (1997). Role of chemokines in antibacterial host defense. Methods Enzymol. 288, 220-241.
10. WILKINSON, P.C., and NEWMAN, I. (1992). Identification of IL-8 as a locomotor attractant for activated human lymphocytes in mononuclear cell cultures with anti-CD3 or purified protein derivative of Mycobacterium tuberculosis. J. Immunol. 149, 2689-2694.
11. BOOM, W.H. (1996). The role of T-cell subsets in Mycobacterium tuberculosis infection. Infect. Agents Dis. 5, 73-81.
12. COOPER, A.M., APPELBERG, R., and ORME, I. (1998). Immunopathogenesis of Mycobacterium avium infection. Front. Biosci. 3, E141-E148.
13. SCHLUGER, N.W., and ROM, W.N. (1998). The host immune response to tuberculosis. Am. J. Respir. Crit, Care Med. 157, 679-691.
14. NEWMAN, G.W., GUARNACCIA, J.R., REMOLD, H.G., and KAZANJIAN, P.H., Jr. (1997). Cytokines enhance neutrophils from human immunodeficiency virus-negative donors and AIDS patients to inhibit the growth of Mycobacterium avium in vitro. J. Infect. Dis. 175, 891-900.
15. NIBBERING, P.H., POS, O., STEVENHAGEN, A., and VAN FURTH, R. (1993). Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes. Infect. Immun, 61, 3111-3116.
16. SILVA, M.T., SILVA, M.N.T., and APPELBERG, R. (1989). Neutrophil-macrophage cooperation in the host defense against mycobacterial infections. Microb. Pathogenesis 6, 369-380.
17. MARODI, L., TOURNAY, C., KAPOSZTA, R., JOHNSTON, R.B., Jr. and MOGUILEVSKY, N. (1998). Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor. Infect. Immun. 66, 2750-2754.
18. SUNDSTROM, C., and NILSSON, K. (1976). Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer 17, 565-577.
19. ACTOR, J.K., KUFFNER, T., DEZZUTTI, C.S., HUNTER, R.L., and McMCHOLL, J. (1998). A flash-type bioluminescent im- munoassay that is more sensitive than radioimaging: quantitative detection of cytokine cDNA in activated and resting human cells. J. Immunol. Methods 211, 65-77.
20. ROSENKRANZ, A.R., SCHMALDIENST, S., STUHLMEIER, K.M., CHEN, W., KNAPP, W., and ZLABINGER, G.J. (1992). A microplate assay for the detection of oxidative products using 2′,7′dichlorofluorescin-diacetate. J. Immunol Methods 156, 39-41.
21. JAGANNATH, C., ACTOR, J.K., and HUNTER, R.L. (1998). Induction of nitric oxide in human monocytes and monocyte derived cell lines. Nitric Oxide: Biol. Chem. 2, 174-186.
22. CROWLE, A.J., TSANG, A.Y., VATTER, A.E., and MAY, M.H. (1986). Comparison of 15 laboratory and patient derived strains of Mycobacterium avium for the ability to infect and multiply in cultured macrophages. J. Clin. Microbiol. 24, 812-821.
23. LIN, Y., ZHANG, M., and BARNES, P.F. (1998). Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect. Immun. 66, 1121-1126.
24. FRIEDLAND, J.S., SHATTOCK, R.J., JOHNSON, J.D., REMICK, D.G., HOLLIMAN, R.E., and GRIFFIN, G.E. (1993) Differential cytokine gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma gondii compared with Mycobacterium tuberculosis. Clin. Exp. Immunol. 91, 282-286.
25. FRIEDLAND, J.S., SHATTOCK, R.J., and GRIFFIN, G.E. (1993). Phagocytosis of Mycobacterium tuberculosis or particulate stimuli by human monocytic cells induces equivalent monocyte chemotactic protein-1 gene expression. Cytokine 5, 150-156.
26. ZHANG, Y., BROSER, M., COHEN, H., BODKIN, M., LAW, K., LEIBMAN, R.J., and ROM, W.N. (1995). Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest. 95, 586-592.
27. FRIEDLAND, J.S., REMICK, D.G., SHATTOCK, R.J., and GRIFFIN, G.E. (1992). Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines. Eur. J. Immunol. 22, 1373-1378.
28. FRIEDLAND, J.S., SHATTOCK, R.J., REMICK, D.G., and GRIFFIN, G.E. (1993). Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin. Exp. Immunol. 91, 58-62.
29. BARNES, P.F., CHATTERJEE, D., ABRAMS, J.S., LU, S., WANG, E., YAMAMURA, M., BRENNAN, P.J., and MODLIN, R.L. (1992). Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J. Immunol. 149, 541-547.
30. CHUJOR, C.S., KUHN, B., SCHWERER, BERNHEIMER, H., LEVIS, W.R., and BEVEC, D. (1992). Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen. Clin. Exp. Immunol. 87, 398-403.
31. FRIEDLAND, J.S., HARTLEY, J.C., HARTLEY, C.G., SHATTOCK, R.J., and GRIFFIN, G.E. (1995). Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection. Clin. Exp. Immunol. 100, 233-238.
32. FRIEDLAND, J.S., HARTLEY, J.C., HARTLEY, C.G., SHATTOCK, R.J., and GRIFFIN, G.E. (1996). Cytokine secretion in vivo and ex vivo following chemotherapy of Mycobacterium tuberculosis infection. Trans. R. Soc. Trop. Med. Hyg. 90, 199-201.
33. KURASHIMA, K., MUKAIDA, N., FUJIMURA, M., YASUI, M., NAKAZUMI, Y., MATSUDA, T., and MATSUSHIMA, K. (1997). Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am. J. Respir. Crit. Care Med. 155, 1474-1477.
34. BERGERON, A., BONAY, M., KAMBOUCHNER, M., LECOSSIER, D., RIQUET, M., SOLER. P., HANCE, P., and TAZI, A. (1997). Cytokine patterns in tuberculosis and sarcoid granulo- mas: correlations with histopathologic features of the granulomatous response. J. Immunol. 159, 3034-3043.
35. YAMAZAKI, Y., KUBO, K., SEKIGUCHI, M., and HONDA, T. (1998). Analysts of BAL fluid in M. avium-intracellulare infection in individuals without predisposing lung disease. Eur. Respir. J. 11, 1227-1231.
36. SUGISAKI, K., DANNENBERG, A.M., Jr., ABE, Y., TSURUTA, J., SU, W.J., SAID, W., FENG, L., YOSHIMURA, T., CONVERSE, P.J., and MOUNTS, P. (1998). Nonspecific and immunespecific up-regulation of cytokines in rabbit dermal tuberculosis (BCG) lesions. J. Leukocyte Biol. 63, 440-450.
37. DANNENBERG, A.M., and ROOK, G.A.W. (1994). Pathogenesis in pulmonary tuberculosis of tissue damaging and macrophage activating immune responses. In: Tuberculosis-Pathogenesis, Protection and Control. B.R. Bloom (ed.) Washington, DC: ASM Press.
38. RIEDEL, D.D., and KAUFMANN, S.H. (1997). Chemokine secretion by human polymorphe nuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect. Immun. 65, 4620-4623.
39. RAMONER, R., RIESER, C., HEROLD, M., KLOCKER, H., BARTSCH, G., STENZL, A., and THURNHER, M. (1998). Activation of human dendritic cells by bacillus Calmette-Guérin. J. Urol. 159, 1488-1492.
40. CONLAN, J.W., and NORTH, R.J. (1996). Neutrophil-mediated dissolution of infected host cells as defense strategy against a facultative intracellular bacterium. J. Exp. Med. 174, 741-744.
41. LAW, K.F., JAGIRDAR, J., WEIDEN, M.D., BODKIN, M., and ROM, W.N. (1996). Tuberculosis in HIV positive patients: cellu- lar response and immune activation in the lung. Am. J. Respir. Crit. Care Med. 153, 1377-1384.
42. FLORIDO, M., APPELBERG, R., ORME, I., and COOPER, A.M. (1997). Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium. Immunology 90, 600-606.
43. DOHERTY, T.M., and SHER, A. (1998). IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice. J. Immunol. 160, 5428-5435.
44. FURNEY, S., SKINNER, P.S., ROBERTS, A.D., APPELBERG, R., and ORME, I. (1992). Capacity of Mycobacterium avium to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect. Immun. 60, 4410-4413.